| CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities K Han, SE Pierce, A Li, K Spees, GR Anderson, JA Seoane, YH Lo, ... Nature 580 (7801), 136-141, 2020 | 271 | 2020 |
| The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses K Blaszczyk, H Nowicka, K Kostyrko, A Antonczyk, J Wesoly, ... Cytokine & growth factor reviews 29, 71-81, 2016 | 163 | 2016 |
| STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1 K Blaszczyk, A Olejnik, H Nowicka, L Ozgyin, YL Chen, S Chmielewski, ... Biochemical Journal 466 (Pt 3), 511, 2015 | 111 | 2015 |
| High-level transgene expression by homologous recombination-mediated gene transfer M Grandjean, PA Girod, D Calabrese, K Kostyrko, M Wicht, F Yerly, ... Nucleic acids research 39 (15), e104-e104, 2011 | 81 | 2011 |
| Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma JW Kim, CP Marquez, K Kostyrko, AL Koehne, K Marini, DR Simpson, ... Nature medicine 25 (11), 1783-1795, 2019 | 64 | 2019 |
| Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy KD Marini, DR Croucher, RA McCloy, V Vaghjiani, A Gonzalez-Rajal, ... Science translational medicine 10 (451), eaat3504, 2018 | 46 | 2018 |
| Assays for DNA double-strand break repair by microhomology-based end-joining repair mechanisms K Kostyrko, N Mermod Nucleic acids research 44 (6), e56-e56, 2016 | 43 | 2016 |
| Combined proteomic and genetic interaction mapping reveals new RAS effector pathways and susceptibilities MR Kelly, K Kostyrko, K Han, NA Mooney, EE Jeng, K Spees, PT Dinh, ... Cancer discovery 10 (12), 1950-1967, 2020 | 37 | 2020 |
| The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas K Valencia, O Erice, K Kostyrko, S Hausmann, E Guruceaga, A Tathireddy, ... The Journal of clinical investigation 130 (4), 1879-1895, 2020 | 35 | 2020 |
| A role for homologous recombination proteins in cell cycle regulation K Kostyrko, S Bosshard, Z Urban, N Mermod Cell Cycle 14 (17), 2853-2861, 2015 | 32 | 2015 |
| MAR‐Mediated transgene integration into permissive chromatin and increased expression by recombination pathway engineering K Kostyrko, S Neuenschwander, T Junier, A Regamey, C Iseli, ... Biotechnology and bioengineering 114 (2), 384-396, 2017 | 28 | 2017 |
| Combined KRASG12C and SOS1 inhibition enhances and extends the anti-tumor response in KRASG12C-driven cancers by addressing intrinsic and acquired resistance V Thatikonda, H Lu, S Jurado, K Kostyrko, CA Bristow, K Bosch, N Feng, ... bioRxiv, 2023 | 15 | 2023 |
| UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma K Kostyrko, M Román, AG Lee, DR Simpson, PT Dinh, SG Leung, ... Nature communications 14 (1), 3966, 2023 | 14 | 2023 |
| Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance V Thatikonda, H Lyu, S Jurado, K Kostyrko, CA Bristow, C Albrecht, ... Nature Cancer 5 (9), 1352-1370, 2024 | 8 | 2024 |
| Combined KRASG12C and SOS1 inhibition enhances and extends the anti-tumor response in KRASG12C-driven cancers by addressing intrinsic and acquired resistance. bioRxiv, 2023 … V Thatikonda, H Lu, S Jurado, K Kostyrko, CA Bristow, K Bosch, N Feng, ... Academic Search, 2023 | 5 | 2023 |
| SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma BR Daley, NE Sealover, E Sheffels, JM Hughes, D Gerlach, MH Hofmann, ... bioRxiv, 2023 | 3 | 2023 |
| Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy … RJ Norgard, P Budhani, SA O'Brien, Y Xia, JN Egan, B Flynn, JR Tagore, ... Cancer Research Communications 4 (6), 1548-1560, 2024 | 2 | 2024 |
| Pharmacological SOS1 inhibitor BI-3406 demonstrates in vivo anti-tumor activity comparable to SOS1 genetic ablation in KRAS mutant tumors FC Baltanas, M Kramer-Drauberg, R Garcia-Navas, E Patrucco, E Petrini, ... bioRxiv, 2024.09. 18.613686, 2024 | 2 | 2024 |
| 25: STAT2 and IRF9-dependent IFN-I signaling restores ISRE-mediated transcription and anti-viral activity independent of STAT1 K Błaszczyk, A Olejnik, S Chmielewski, K Kostyrko, J Wesoly, CK Lee, ... Cytokine 63 (3), 248-249, 2013 | 2 | 2013 |
| SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma BR Daley, NE Sealover, BA Finniff, JM Hughes, E Sheffels, D Gerlach, ... Cancer Research 85 (1), 118-133, 2025 | 1 | 2025 |
Peter K JacksonStanford University School of MedicineVerified email at stanford.edu